In short. Injecting a mixture adds risks that a single product does not carry. What they are, how they appear, and which ones need attention rather than waiting.
Key points
- The mixture, the areas, the date and who treated you.
- With a manufactured product you would have the box and the batch details.
- With a prepared mixture the record is the only equivalent, and it is the thing a clinician will ask for if anything appears later.
Every injection carries the risks of injection: pain, bleeding, bruising, infection at the site, and the rare event in which material enters a blood vessel and threatens the skin or, exceptionally, the vision. Those belong to needles and are not specific to mesotherapy. What is specific is that the substance is often a mixture rather than a single standardised product, and that changes the picture in ways worth stating plainly.
Allergy: more ingredients, more chances
Every additional ingredient is an additional exposure for the immune system. A mixture of vitamins, plant extracts and preservatives presents several at once, in a way a single well-characterised product does not, and reactions can be immediate or delayed. A history of reacting to an injected substance, or a tendency to react to cosmetics and topical products, is information the assessment needs.
Nodules and firm lumps
Firm lumps under the skin are the complication that arrives late, sometimes months after a session and sometimes after an unrelated illness. They are described more often with mixtures that are not standardised than with single licensed products, which is one of the practical costs of that. A nodule is assessed rather than simply injected again, and the date it appeared is part of how it is judged.
Write down what went in, while you still can
The mixture, the areas, the date and who treated you. With a manufactured product you would have the box and the batch details. With a prepared mixture the record is the only equivalent, and it is the thing a clinician will ask for if anything appears later.
Unknown contents as a risk in itself
Where a plan cannot be written as a list of substances, neither you nor a later clinician can reason about what is under your skin, and that is the risk patients find hardest to accept afterwards. It is also the one most easily avoided, since it is a matter of asking before the session rather than after. The same covers prescription ingredients added for a local effect, which can interact with medication you already take.
Infection and how a mixture is handled
Any injection can introduce infection, and the handling of a mixture prepared outside a licensed manufacturing process is a further variable. Standards of preparation and storage are the part of this a patient cannot see, which is why the institution and the clinician are part of the risk assessment. Where redness, warmth, spreading pain or fever appears in the days after a session, seek care promptly.
These need care rather than a review appointment
- Severe pain out of proportion to the procedure, or skin turning white, grey or dusky.
- Fever with spreading redness, warmth or discharge at the treated area.
- Any change in vision, which requires emergency care.
How to read a plan before agreeing to it is set out in What Is in the Injection?, and the groups who should not be treated at all are covered in Who Should Not Have It.
Frequently asked questions
How soon would an allergic reaction show up?
It can be immediate, within minutes of the injections, or delayed over days to weeks. Immediate reactions are the ones that need attention at the time, which is one reason injections are given where a clinician can respond. A delayed reaction is usually a firm area, itching or redness appearing later, and it should be reported when it appears rather than at a scheduled review.
What does a nodule feel like and when does it appear?
A firm lump under the skin, sometimes tender, often noticed weeks or months after a session rather than the next day, and sometimes after an unrelated illness. It is assessed rather than simply injected again, and the date it appeared is part of that assessment, which is why writing it down is worth the trouble.
Do these risks mean I should not have the treatment at all?
They mean the decision should be made with the risks in view rather than around them. Most people who have an injection do not have a serious complication, and the risks that matter here are harder to reason about because the mixture is not standardised. If that uncertainty is not acceptable to you, that is a good reason not to proceed.
Risks & Limitations
- Mesotherapy names a technique, not a product. The mixture is often prepared rather than manufactured, and it has not been assessed as a mixture.
- Any change reported is usually modest, lies in surface quality rather than in volume, and fades without further sessions.
- Firm lumps and delayed reactions can appear weeks to months after a session, and the date they appear is part of how they are assessed.
- A mixture is not standardised between clinics or between sessions, so the evidence for one plan says nothing about the next.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky, needs immediate assessment.
- Any change in vision after an injection requires emergency care.
- Fever, or redness, warmth or discharge at a treated area that is spreading rather than settling.
- A firm lump or nodule appearing weeks or months later, which should be reported when noticed rather than at a review.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.